Seung-seob Kim

Dr. Seung-seob Kim

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
SKSunkyu Kim
Sunkyu Kim
CLChoong-Kun Lee
Choong-Kun Lee
SKSeung-seob Kim
Seung-seob Kim
Kim S, et al. Korean J Radiol. 2024 Feb;25(2):126-133. https://doi.org/10.3348/kjr.2023.0997

1 September 2017 in American Journal of Roentgenology
Verified
Journal Article
Open access
CAChansik An
Chansik An
SPSumi Park
Sumi Park
YCYong Eun Chung
Yong Eun Chung
DKDo-Young Kim
Do-Young Kim
SKSeung-seob Kim
Seung-seob Kim
JCJin-Young Choi
Jin-Young Choi
OBJECTIVE. The purpose of this study was to examine the associations between preoperative Liver Imaging Reporting and Data System (LI-RADS) categories and prognosis after curative resection of single hepatic malignancies in patients with chronic liver disease. MATERIALS AND METHODS. Between January 2008 and December 2010, 225 patients with chronic liver disease underwent resection of single hepatic malignant tumors (218 hepatocellular carcinomas, three cholangiocarcinomas, four biphenotypic carcinomas) after undergoing gadoxetic acid–enhanced MRI. Two radiologists retrospectively categorized the tumors into LI-RADS categories. Differences in disease-free survival duration between categories were analyzed by the Kaplan-Meier method with the log-rank test. RESULTS. Reviewer 1 categorized two (0.9%) patients as having LR-3, 53 (23.6%) LR-4, 159 (70.7%) LR-5, and 11 (4.9%) LR-M lesions. The corresponding numbers for reviewer 2 were six (2.7%) LR-3, 30 (13.3%) LR-4, 178 (79.1%) LR-5, and 11 (4.9%) LR-M. The 2-...

4 December 2019 in Hepatology International
Verified
Journal Article
Closed access
PDF file
SLSunyoung Lee
Sunyoung Lee
MKMyeong-Jin Kim
Myeong-Jin Kim
SKSeung-seob Kim
Seung-seob Kim
HSHyejung Shin
Hyejung Shin
DKDo Young Kim
Do Young Kim
DMDonald G. Mitchell
Donald G. Mitchell

26 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
HKHuapyong Kang
Huapyong Kang
SKSeung-seob Kim
Seung-seob Kim
MSMin Je Sung
Min Je Sung
JJJung Hyun Jo
Jung Hyun Jo
HLHee Seung Lee
Hee Seung Lee
SBSeungmin Bang
Seungmin Bang
The 8th edition of the American Joint Committee on Cancer (AJCC) staging system for pancreatic cancer (PC) has been validated for pathological staging; however, its significance for clinical staging remains uncertain. We validated the prognostic performance and suitability of the current staging system for the clinical staging of PC. We identified 1043 patients from our PC registry who were staged by imaging according to the 8th edition staging system and conducted analysis, including overall survival (OS) comparison. Gradual prognostic stratification according to stage hierarchy yielded significant OS differences between stage groups, except between stage I and II (p = 0.193). A substage comparison revealed no survival differences between IB (T2N0) and IIA (T3N0), which were divided by the T3 criterion only (p = 0.278). A higher N stage had significantly shorter OS than a lower N stage (all pairwise p < 0.05). However, among the 150 patients who received upfront surgery, the pathological stage was more advanced than the clinical stage in 86 (57.3%), mostly due to a false-negative cN0 (70.9%). Our results suggest that the new definition of T3 and the number-based N criteria in the 8th edition AJCC staging system may be not adequate for clinical staging. Establishing separate criteria more suitable for clinical staging should be considered.

1 June 2022 in Radiology
Verified
Journal Article
Closed access
SKSeung-seob Kim
Seung-seob Kim
SLSunyoung Lee
Sunyoung Lee
HLHee Seung Lee
Hee Seung Lee
SBSeungmin Bang
Seungmin Bang
KHKyunghwa Han
Kyunghwa Han
MPMi-Suk Park
Mi-Suk Park
Integrated evaluation of treatment response with CT and carbohydrate antigen 19-9 allowed more accurate survival stratification of patients with pancreatic ductal adenocarcinoma than did evaluation... Background Imaging studies have limitations in evaluating pancreatic ductal adenocarcinoma (PDAC) treatment response. Purpose To investigate the effectiveness of combined CT and carbohydrate antige...

1 April 2024 in Radiology
Verified
Journal Article
Closed access
JYJeong Hee Yoon
Jeong Hee Yoon
YKYoung Kon Kim
Young Kon Kim
JKJeong Woo Kim
Jeong Woo Kim
WCWon Chang
Won Chang
JCJOON-IL CHOI
JOON-IL CHOI
SLSang Min Lee
Sang Min Lee
Among four hepatocellular carcinoma diagnosis guidelines and by using MRI with hepatobiliary contrast agent, Eastern guidelines offered higher sensitivity whereas Western guidelines provided higher specificity in patients with cirrhosis and in those with chronic hepatitis B.